These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 26886220)
1. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer. Huang Z; Xu D; Zhang F; Ying Y; Song L Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy. Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241 [TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer. Nisman B; Heching N; Biran H; Barak V; Peretz T Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245 [TBL] [Abstract][Full Text] [Related]
4. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer? Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424 [TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement. Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089 [TBL] [Abstract][Full Text] [Related]
6. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer. Schneider J; Philipp M; Salewski L; Velcovsky HG Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474 [TBL] [Abstract][Full Text] [Related]
7. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Shibayama T; Ueoka H; Nishii K; Kiura K; Tabata M; Miyatake K; Kitajima T; Harada M Lung Cancer; 2001 Apr; 32(1):61-9. PubMed ID: 11282430 [TBL] [Abstract][Full Text] [Related]
8. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment in Patients with Small Cell Lung Cancer]. Peng Y; Wang Y; Li J; Hao X; Hu X Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):590-4. PubMed ID: 27666548 [TBL] [Abstract][Full Text] [Related]
9. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency]. Shen D; Han BB; Chen F; Wei BJ; Cui CJ; Wang GJ; Cui W Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2657-2662. PubMed ID: 28910952 [No Abstract] [Full Text] [Related]
10. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China. Wu XY; Hu YB; Li HJ; Wan B; Zhang CX; Zhang B; Hu H; Zhang Q; Lv TF; Zhan P; Song Y J Cell Mol Med; 2018 Sep; 22(9):4328-4334. PubMed ID: 29989303 [TBL] [Abstract][Full Text] [Related]
11. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318 [TBL] [Abstract][Full Text] [Related]
12. Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer. Ono A; Naito T; Ito I; Watanabe R; Shukuya T; Kenmotsu H; Tsuya A; Nakamura Y; Murakami H; Kaira K; Takahashi T; Kameya T; Nakajima T; Endo M; Yamamoto N Lung Cancer; 2012 Jun; 76(3):439-44. PubMed ID: 22300752 [TBL] [Abstract][Full Text] [Related]
13. The diagnostic and prognostic value of ProGRP in lung cancer. Nisman B; Biran H; Ramu N; Heching N; Barak V; Peretz T Anticancer Res; 2009 Nov; 29(11):4827-32. PubMed ID: 20032442 [TBL] [Abstract][Full Text] [Related]
14. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer. Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer. Petrović M; Bukumirić Z; Zdravković V; Mitrović S; Atkinson HD; Jurišić V Med Oncol; 2014 Feb; 31(2):823. PubMed ID: 24375395 [TBL] [Abstract][Full Text] [Related]
16. Multiplexing determination of small cell lung cancer biomarkers and their isovariants in serum by immunocapture LC-MS/MS. Torsetnes SB; Levernæs MS; Broughton MN; Paus E; Halvorsen TG; Reubsaet L Anal Chem; 2014 Jul; 86(14):6983-92. PubMed ID: 24945626 [TBL] [Abstract][Full Text] [Related]
18. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer. Holdenrieder S; von Pawel J; Dankelmann E; Duell T; Faderl B; Markus A; Siakavara M; Wagner H; Feldmann K; Hoffmann H; Raith H; Nagel D; Stieber P Clin Cancer Res; 2008 Dec; 14(23):7813-21. PubMed ID: 19047109 [TBL] [Abstract][Full Text] [Related]
19. Selective application of neuroendocrine markers in the diagnosis and treatment of small cell lung cancer. Du J; Li Y; Wang L; Zhou Y; Shen Y; Xu F; Chen Y Clin Chim Acta; 2020 Oct; 509():295-303. PubMed ID: 32592711 [TBL] [Abstract][Full Text] [Related]
20. Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase. Takada M; Kusunoki Y; Masuda N; Matui K; Yana T; Ushijima S; Iida K; Tamura K; Komiya T; Kawase I; Kikui N; Morino H; Fukuoka M Br J Cancer; 1996 May; 73(10):1227-32. PubMed ID: 8630283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]